Last reviewed: June 12, 2026

Last updated: June 12, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injections work by mimicking glucagon-like peptide-1, a natural hormone that regulates appetite and blood sugar. Clinical trials show that semaglutide leads to an average weight loss of 15–22% of body weight over 68 weeks when combined with lifestyle changes. PlexusDx delivers personalized semaglutide therapy through licensed 503A compounding pharmacies to patients across all 50 states.

How Semaglutide Injections Work in Your Body

Semaglutide is a glucagon-like peptide-1 receptor agonist, meaning it binds to specific GLP-1 receptors found throughout your body. These receptors sit on nerve cells in your brain's appetite center (the hypothalamus) and on beta cells in your pancreas that produce insulin. When semaglutide activates these receptors, it sends strong signals that you are full, even when you have eaten less food than usual.

The medication also slows how fast your stomach empties food into your small intestine, extending the feeling of fullness after meals. At the same time, semaglutide improves how your pancreas releases insulin in response to blood sugar changes, helping stabilize glucose levels between meals. This dual action on appetite suppression and metabolic regulation makes semaglutide effective for weight management in people with and without type 2 diabetes.

Unlike older weight loss medications that act only in the brain or liver, semaglutide's effects are widespread because GLP-1 receptors exist in multiple organ systems. Your brain recognizes the medication's signal and reduces hunger hormones like ghrelin, while your gut responds by producing more of the fullness hormone peptide YY. This coordinated response creates a powerful, sustained reduction in calorie intake without requiring constant willpower.

Weight Loss Results from Semaglutide Therapy

Clinical evidence demonstrates that semaglutide injections produce meaningful weight reduction across diverse patient populations. In the STEP 1 trial, adults without diabetes who received semaglutide lost an average of 14.9% of their starting body weight over 68 weeks, compared to 2.4% in the placebo group. Patients on higher doses achieved even greater results, with some losing 20% or more of their body weight when combined with reduced calorie intake and increased physical activity.

Weight loss typically begins within the first 2–4 weeks as your appetite diminishes and meal sizes naturally decrease. Most patients experience the largest reductions during months 2–6, with continued gradual loss through month 10–12. PlexusDx's personalized approach, including optional genetic testing through the Precision Peptide Genetic Test, helps identify whether your GLP-1 receptor genetics may influence your individual response to semaglutide therapy.

Beyond the number on the scale, semaglutide reduces visceral fat (belly fat around organs), which is linked to heart disease, type 2 diabetes, and metabolic syndrome. Studies show that 85% of patients on semaglutide achieve at least 5% weight loss, and two-thirds achieve 10% or more. These outcomes remain sustained as long as you continue the medication and maintain healthier eating patterns.

Semaglutide's Effects on Blood Sugar and Metabolic Health

Semaglutide lowers fasting blood sugar by enhancing your pancreas's natural ability to sense glucose levels and release appropriate amounts of insulin. In people with prediabetes, this mechanism can prevent or delay the onset of type 2 diabetes. Among patients with existing type 2 diabetes, semaglutide reduces hemoglobin A1C (a three-month average of blood sugar) by approximately 1.5–2 percentage points, rivaling or exceeding the effect of many dedicated diabetes medications.

The medication also improves insulin sensitivity, meaning your cells become more responsive to the insulin your body produces. This improvement persists even as you lose weight, because semaglutide works on the metabolic pathways directly rather than only through weight reduction alone. Many patients experience more stable energy levels throughout the day and fewer afternoon crashes in focus or mood.

Cardiovascular benefits have emerged in large trials, with semaglutide reducing the risk of major adverse cardiac events by 26% in patients with existing heart disease or high cardiovascular risk. These protective effects extend beyond weight loss and likely involve semaglutide's direct action on heart and blood vessel cells.

PlexusDx Compounded Semaglutide: Personalized Access and Affordability

PlexusDx provides semaglutide injections prepared by licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality without the markup of brand-name products. PlexusDx's flat monthly pricing model starts at $149/month, with your dose able to increase as medically appropriate without price changes. No insurance is required, no membership fees apply, and coverage extends to all 50 states, making personalized GLP-1 therapy accessible to a broader population.

HSA and FSA accounts can be used to pay for PlexusDx semaglutide, reducing out-of-pocket costs for eligible patients. For those seeking deeper insight into their genetic predisposition to respond well to semaglutide, PlexusDx offers the Precision Peptide Genetic Test for $99 after your first month of treatment. This test analyzes 14 peptide pathways and 150+ genetic insights, including key GLP-1 receptor variants like rs6923761, helping your clinician fine-tune your therapy plan.

PlexusDx coordinates all prescriptions, pharmacy logistics, and clinical support through its network of licensed compounding partners. You receive your injections at home on a regular schedule, with easy online account management and direct communication with PlexusDx's clinical team. This streamlined model eliminates the barriers—insurance denials, long appointment waits, pharmacy transfers—that often prevent people from accessing GLP-1 therapy.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How quickly will I see weight loss results from semaglutide injections?

Most patients notice reduced appetite within 3–7 days of starting semaglutide, with measurable weight loss appearing in weeks 2–4. The largest reductions typically occur between months 2 and 6, though continued gradual weight loss can persist for up to 12 months or longer. PlexusDx's clinicians monitor your progress and adjust your dose as needed to optimize results while keeping your monthly cost flat.

Does semaglutide work if you have type 2 diabetes or prediabetes?

Yes, clinical trials confirm that semaglutide is highly effective for both conditions. In people with type 2 diabetes, it reduces hemoglobin A1C by 1.5–2 percentage points while promoting weight loss. In those with prediabetes, it can prevent diabetes onset by 63% over three years, addressing the root metabolic dysfunction rather than just weight.

What does PlexusDx's Precision Peptide Genetic Test reveal about semaglutide response?

The test analyzes your GLP-1 receptor gene (including rs6923761), GIPR variant (rs1800437), FTO (rs9939609), and MC4R (rs17782313) to map 14 peptide pathways and predict how your body may respond to semaglutide. PlexusDx uses these insights to personalize your therapy plan, ensuring you start at the right dose and progression for your genetic profile. The test costs $99 after your first month of treatment.

Are there common side effects with semaglutide injections?

Mild nausea, vomiting, and constipation are the most frequent side effects, especially during the first 2–4 weeks, and typically diminish as your body adjusts. Serious side effects are rare but include acute pancreatitis and gallbladder complications; report severe abdominal pain to your doctor immediately. PlexusDx's clinical team monitors for adverse effects and can adjust your dose or discuss mitigation strategies to keep you safe and comfortable.

Can I use my HSA or FSA to pay for PlexusDx semaglutide?

Yes, semaglutide injections from PlexusDx are eligible for HSA and FSA reimbursement, reducing your out-of-pocket cost. PlexusDx starts at $149/month for compounded semaglutide with no insurance required, and your dose can increase without price increases, making this an affordable, accountable way to access personalized GLP-1 therapy across all 50 states.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves